Assessing the Effectiveness of Psychiatric Interventions on the Inpatient Unit



Status:Recruiting
Conditions:Depression
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:12/2/2018
Start Date:July 9, 2018
End Date:December 1, 2020
Contact:Eleanor Cole, PhD
Email:ecole@stanford.edu
Phone:4157247960

Use our guide to learn which trials are right for you!

This study will monitor the symptoms of patients who have received an intervention on the
psychiatric inpatient unit at Stanford hospital up to 6 months after they have received the
intervention. Additionally, the acceptability and feasibility of interventions will be
assessed using clinician and patient questionnaires.

Once patients have been discharged from hospital they will be contacted weekly for 4 weeks,
at 6 and 8 weeks after the intervention and then monthly until 6 months post-intervention in
order to monitor their symptoms. Participants will have consented to be contacted at these
regular intervals before being discharged from the inpatient unit. During the weekly and
fortnightly follow-up sessions, the following assessments will be conducted:
Montgomery-Åsberg Depression Rating Scale (MADRS) Scale of suicidal ideation (SSI) Hamilton
depression rating scale (HAMD-6) Young Mania Rating Scale (YMRS) Pittsburgh insomnia rating
scale (PIRS-20) Quick inventory of depressive symptomatology (QIDS) Immediate Mood Scaler
(IMS-12) Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q- SF)
Questionnaires regarding the symptoms associated with the participant's preliminary
psychiatric diagnosis (if not MDD) will also be administered.

The monthly follow-ups (3-6 months after discharge) will involve the following assessments:

HAMD-6 QIDS Immediate Mood Scaler (IMS-12) Quality of Life Enjoyment and Satisfaction
Questionnaire - Short Form (Q-LES-Q- SF) Questionnaires regarding the symptoms associated
with the participant's preliminary psychiatric diagnosis (if not MDD) will also be
administered.

The questionnaires that will be used to assess symptoms associated with primary psychiatric
diagnoses are:

- Bipolar disorder: YMRS

- Schizoaffective disorder/ Schizophrenia/Schizophreniform disorder: positive and negative
symptom scale (PANSS) and the Calgary Depression Scale for Schizophrenia (CDSS)

- Alcohol use disorder: Alcohol craving questionnaire self-report (ACQ-SR) and obsessive
compulsive drinking scale (OCDS)

- Drug use disorders: Modified versions of the alcohol scales to make these relevant to
the particular drug of abuse.

- Anorexia Nervosa: Yale-Brown-Cornell Eating Disorder Scale [YBC-EDS], Eating disorder
examination questionnaire (EDE-Q)

- Bulimia Nervosa: Yale-Brown-Cornell Eating Disorder Scale [YBC-EDS], Eating disorder
examination questionnaire (EDE-Q)

- Binge eating disorder: Young-Brown Obsessive Compulsive Scale Modified for Binge Eating
[YBOCS-BE]

- OCD: Obsessive compulsive inventory (OCI) and Yale-Brown Obsessive Compulsive Scale
(YBOCS)

- PTSD: Post-traumatic Stress Disorder Checklist-Civilian Version [PCL-C]

- Generalized anxiety disorder: Generalized Anxiety Disorder 7-item (GAD-7) scale

- Chronic pain: Numeric Rating Scale (NRS) for Chronic Pain

- Panic Disorder: Panic Disorder Severity Scale (PDSS)

- Somatoform Disorders: The Somatic Symptom Scale (SSS-8)

- Impulse Control disorders: Massachusetts General Hospital Hairpulling Scale (This
questionnaire will be adapted depending on the urges the patient cannot control e.g.
compulsive picking) BPD: The Borderline Evaluation of Severity Over Time (BEST)

Inclusion Criteria:

- Received an intervention on the psychiatric inpatient unit at Stanford Hospital aimed
at treating a major depressive episode or suicidal ideation

Exclusion Criteria:
We found this trial at
1
site
Palo Alto, California 94305
Phone: 415-724-7960
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials